Clinical trial
Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study
NCT04602949 is registered in ClinicalTrials.gov with Scentech Medical Technologies Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study
- Lead sponsor
- Scentech Medical Technologies Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 12, 2020
- Completion date
- January 18, 2023
- Enrollment
- 2,558 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19